A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Clinical trial NCT02397954 · COMPLETED
Trial details
- NCT number
- NCT02397954
- Sponsor
- Ophthotech Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-12
- Primary completion
- 2015-10-23
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.